Cargando…

单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析

BACKGROUND AND OBJECTIVE: In recent years, the technique of uniportal video-assisted thoracoscopic surgery has been developed. As a new surgical method, its feasibility and safety have not been generally recognized. The aim of this study is to review the technology in the treatment of lung cancer pa...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 中国肺癌杂志编辑部 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406445/
https://www.ncbi.nlm.nih.gov/pubmed/32455516
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.23
_version_ 1783567423788548096
collection PubMed
description BACKGROUND AND OBJECTIVE: In recent years, the technique of uniportal video-assisted thoracoscopic surgery has been developed. As a new surgical method, its feasibility and safety have not been generally recognized. The aim of this study is to review the technology in the treatment of lung cancer patients in stage Ⅰ to part of stage IIIa. METHODS: The clinical data of patients accepted thoracoscopic resection of lung cancer by a same medical group from May 2018 to March 2019 in The First Affiliated Hospital of Soochow University were retrospectively analyzed. After remove of cases that did not meet the requirements, the patients were divided into uniportal group (55 cases) and biportal group (87 cases). The clinical data of the two groups were collected and statistically analyzed. RESULTS: All the 142 patients underwent lobectomy and systemic lymph node dissection. There is no perioperative death in both groups. There was no significant difference in age, location of tumors, pathological type, size of tumors and pathological tumor-node-metastasis (pTNM) staging between uniportal group and biportal group (P > 0.05). The operation time [(167.65±43.85) min vs (181.71±51.28) min], the intraoperative bleeding volume [(57.45±50.19) mL vs (87.47±132.54) mL], the indwelling time of drainage tube [(4.82±2.82) d vs (5.84±3.43) d] and the hospital stay [(6.91±3.88) d vs (7.74±3.87) d] were less in uiportal group compared to biportal group, though no significant difference occurred (P > 0.05). The total drainage volume of uniportal group was significantly lower than that of biportal group [(1, 064.82±776.38) mL vs (1, 658.71±1, 722.38) mL], and the visual analogue score of 24 hours and 72 hours after operation [(4.73±0.73) points vs (5.25±0.74) points; (2.16±0.71) points vs (2.55±0.86) points] were lower in uniportal group (P < 0.05). CONCLUSION: Uniportal video-assisted thoracoscopic radical resection of lung cancer is safe and feasible for stage Ⅰ to part of stage IIIa lung cancer patients.
format Online
Article
Text
id pubmed-7406445
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher 中国肺癌杂志编辑部
record_format MEDLINE/PubMed
spelling pubmed-74064452020-08-13 单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析 Zhongguo Fei Ai Za Zhi 临床研究 BACKGROUND AND OBJECTIVE: In recent years, the technique of uniportal video-assisted thoracoscopic surgery has been developed. As a new surgical method, its feasibility and safety have not been generally recognized. The aim of this study is to review the technology in the treatment of lung cancer patients in stage Ⅰ to part of stage IIIa. METHODS: The clinical data of patients accepted thoracoscopic resection of lung cancer by a same medical group from May 2018 to March 2019 in The First Affiliated Hospital of Soochow University were retrospectively analyzed. After remove of cases that did not meet the requirements, the patients were divided into uniportal group (55 cases) and biportal group (87 cases). The clinical data of the two groups were collected and statistically analyzed. RESULTS: All the 142 patients underwent lobectomy and systemic lymph node dissection. There is no perioperative death in both groups. There was no significant difference in age, location of tumors, pathological type, size of tumors and pathological tumor-node-metastasis (pTNM) staging between uniportal group and biportal group (P > 0.05). The operation time [(167.65±43.85) min vs (181.71±51.28) min], the intraoperative bleeding volume [(57.45±50.19) mL vs (87.47±132.54) mL], the indwelling time of drainage tube [(4.82±2.82) d vs (5.84±3.43) d] and the hospital stay [(6.91±3.88) d vs (7.74±3.87) d] were less in uiportal group compared to biportal group, though no significant difference occurred (P > 0.05). The total drainage volume of uniportal group was significantly lower than that of biportal group [(1, 064.82±776.38) mL vs (1, 658.71±1, 722.38) mL], and the visual analogue score of 24 hours and 72 hours after operation [(4.73±0.73) points vs (5.25±0.74) points; (2.16±0.71) points vs (2.55±0.86) points] were lower in uniportal group (P < 0.05). CONCLUSION: Uniportal video-assisted thoracoscopic radical resection of lung cancer is safe and feasible for stage Ⅰ to part of stage IIIa lung cancer patients. 中国肺癌杂志编辑部 2020-07-20 /pmc/articles/PMC7406445/ /pubmed/32455516 http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.23 Text en 版权所有©《中国肺癌杂志》编辑部2020 This is an open access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 3.0) License. See: https://creativecommons.org/licenses/by/3.0/.
spellingShingle 临床研究
单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析
title 单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析
title_full 单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析
title_fullStr 单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析
title_full_unstemmed 单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析
title_short 单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析
title_sort 单孔和单操作孔胸腔镜技术在肺癌外科治疗中的临床效果分析
topic 临床研究
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406445/
https://www.ncbi.nlm.nih.gov/pubmed/32455516
http://dx.doi.org/10.3779/j.issn.1009-3419.2020.101.23
work_keys_str_mv AT dānkǒnghédāncāozuòkǒngxiōngqiāngjìngjìshùzàifèiáiwàikēzhìliáozhōngdelínchuángxiàoguǒfēnxī
AT dānkǒnghédāncāozuòkǒngxiōngqiāngjìngjìshùzàifèiáiwàikēzhìliáozhōngdelínchuángxiàoguǒfēnxī
AT dānkǒnghédāncāozuòkǒngxiōngqiāngjìngjìshùzàifèiáiwàikēzhìliáozhōngdelínchuángxiàoguǒfēnxī
AT dānkǒnghédāncāozuòkǒngxiōngqiāngjìngjìshùzàifèiáiwàikēzhìliáozhōngdelínchuángxiàoguǒfēnxī
AT dānkǒnghédāncāozuòkǒngxiōngqiāngjìngjìshùzàifèiáiwàikēzhìliáozhōngdelínchuángxiàoguǒfēnxī
AT dānkǒnghédāncāozuòkǒngxiōngqiāngjìngjìshùzàifèiáiwàikēzhìliáozhōngdelínchuángxiàoguǒfēnxī
AT dānkǒnghédāncāozuòkǒngxiōngqiāngjìngjìshùzàifèiáiwàikēzhìliáozhōngdelínchuángxiàoguǒfēnxī